TEAM
Jun Wu, Ph.D.
Chairman and Managing Partner Cenova Capital
BOARD OF DIRECTORS
Dr. Wu founded Cenova Capital in 2010, one of the earliest healthcare sector-specific GPs in China. Prior to Cenova, Dr. Wu co-founded Shanghai Genomics in 2001, one of the earliest and most successful life science company in China. The company was the first China biotechnology company listed on a major international stock exchange (2007 in TSE), and successfully developed a billion-dollar drug (pirfenidone) in China. Dr. Wu was a recipient of the prestigious ‘National Outstanding Young Scientist Award’ in 2002 from the Chinese National Science Foundation. He also made important contributions in the field of immuno-oncology and has published over thirty high-quality research papers in professional journals, including Science and Nature.
Dr. Wu received his Ph.D. degree in Immunology from University of California, San Francisco, and majored in Clinical Medicine in Shanghai Fudan University Medical School.
© Copyright AceLink Therapeutics. All rights reserved